![Jeff Caravella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Caravella
Directeur Financier/CFO chez
ABIOMED, INC.
Profil
Jeff Caravella is currently Chief Financial Officer at ABIOMED, Inc. since 2025.
Formerly, Mr. Caravella was Chief Financial Officer at BioTheryX, Inc. and Chief Financial Officer at Medicenna Therapeutics Corp.
in 2023.
Education includes undergraduate and MBAistration degrees from Syracuse University.
Postes actifs de Jeff Caravella
| Sociétés | Poste | Début |
|---|---|---|
| ABIOMED, INC. | Directeur Financier/CFO | 01/01/2025 |
Anciens postes connus de Jeff Caravella
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur Financier/CFO | 26/10/2023 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Directeur Financier/CFO | - |
Formation de Jeff Caravella
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
